Publikationen 2002
Can antiretroviral therapy be used to prevent sexual transmission of human immunodefiency virus type 1?
Hosseinipour M, Cohen MS, Vernazza PL
CID 2002;34:1391-5
[abstract] [full-text/pdf]
A Randomized Trial of Simplified Maintenance Therapy with Abacavir, Lamivudine, and Zidovudine in Human Immunodeficiency Virus Infection
Opravil M, Hirschel B, Lazzarin A, Furrer H., Chave JP, Yerly S, Bisset LR, Fischer M, Vernazza P, Bernasconi E, Battegay M, Ledergerber B, Günthard H, Howe C, Weber R and the SHCS
JID 2002;185:1251-60
[abstract] [full-text/pdf]
The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women
van Benthem B, Vernazza PL, Coutinho RA and Prins M for the European Study on the Natural History of HIV Infection in Women and the Swiss HIV Cohort Study
AIDS 2002;16:919-924
[abstract] [full-text/pdf]
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
Fellay J, Marzolini C, Meaden ER, Back DJ, Buclin T, Chave JP, Decosterd LA, Furrer HJ, Opravil M, Pantaleo G, Retelska D, Ruiz L, Schinkel AH, Vernazza PL, Eap CE
Lancet 2002;359:30-36
[abstract] [full-text/pdf]
Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study
Taffé P, Rickenbach P, Hirschel B, Opravil M, Furrer HJ, Janin P, Bugnon F, Ledergerber B, Wagels T, Sudre P and the Swiss HIV Cohort Study
AIDS 2002;16:747-755
[abstract] [full-text/pdf]
Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case-control study from the Swiss HIV Cohort
Hirschel B, Flepp M, Bucher HC, Zellweger C, Telenti A, Wagels T, Bernasconi E, Ledergerber B and the Swiss HIV Cohort
AIDS 2002;16:381-385
[abstract] [full-text/pdf]
Cytotoxic HIV – 1 p55gag-Specific CD4+ T Cells Produce HIV-Inhibitory Cytokines and Chemokines.
Lotti B, Wendland T, Furrer H, Yawalkar N, von Greyerz S, Schnyder K, Brandes M, Vernazza P, Wagner R, Nguyen T, Rosenbeg E, Pichler W, Brander C
JCI 2002; 22:253-262
Prospective epidemiologic survey of patients with community-acquired pneumonia requiring hospitalization in Switzerland
Garbino J, Sommer R. Gerber A, Regamey C, Vernazza P, Genné D., Dür P, Rothen M, Unger J P, Lew D
IJID 2002;6:288-293
HIV-Impfung: kein Land in Sicht
Vernazza P
SMF 2002;51/52:1223-1224
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy
Greub G, Cozzi-Lepri A, Ledergerber B, Staszewski S, Perrin L, Miller V, Francioli P, Furrer H, Battegay M, Vernazza P, Bernasconi E, Günthard H, Hirschel B, Phillips A, Telenti A, for the Frankfurt HIV Clinic Cohort and the Swiss HIV Cohort Study.
AIDS 2002; 16(14):1967-1969
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients and the Swiss HIV Cohort Study
Bucher HC, Bichsel M, Taffé P, Furrer H, Telenti A, Hirschel B, Weber R, Bernasconi E, Vernazza P, Minder C, Battegay M and the Swiss HIV Cohort Study
HIV Med. 2002 Oct;3(4):247-53
